Wada, N.; Murakami, T.; Fauzi, M.; Sakaki, K.; Oshima, S.; Shimada, Y.; Asai, K.; Oshima, A.; Nomura, S.; Joo, E.; Mori, M.; Fujiwara, R.; Shide, K.; Wada, K.; Yabe, D.; Inagaki, N.; Harada, N. Elevated Serum Growth Differentiation Factor 15 Levels As a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study. J Clin Med Res 2024, 16 (10), 503-508. https://doi.org/10.14740/jocmr6031.